Cargando…
The Molecular Pathogenesis of Osteosarcoma: A Review
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapid growth and primarily affects adolescents and young adults. The 5-year survival rate for osteosarcoma is 60%–70%, with no significant improvements in prognosis since the advent of multiagent chemothe...
Autores principales: | Broadhead, Matthew L., Clark, Jonathan C. M., Myers, Damian E., Dass, Crispin R., Choong, Peter F. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087974/ https://www.ncbi.nlm.nih.gov/pubmed/21559216 http://dx.doi.org/10.1155/2011/959248 |
Ejemplares similares
-
Efficacy of Continuously Administered PEDF-Derived Synthetic
Peptides against Osteosarcoma Growth and Metastasis
por: Broadhead, Matthew L., et al.
Publicado: (2012) -
Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model
por: Broadhead, M L, et al.
Publicado: (2011) -
Applying Advanced Imaging Techniques to a Murine Model of Orthotopic Osteosarcoma
por: Broadhead, Matthew L., et al.
Publicado: (2015) -
Cell and Molecular Biology Underpinning the Effects of PEDF on Cancers in General and Osteosarcoma in Particular
por: Chandolu, Vijay, et al.
Publicado: (2012) -
Targeting of small molecule anticancer drugs to the tumour and its vasculature using cationic liposomes: lessons from gene therapy
por: Dass, Crispin R, et al.
Publicado: (2006)